Overall Status

Completed (1)

Enrolling by invitation (1)

Recruiting (1)

Unknown status (1)

Phase

n/a (2)

Sponsor

Aarhus University Hospital (1)

University Hospital, Tours (1)

Wroclaw Medical University (1)

Zhebao Wu (1)

Collaborator

Beijing Tiantan Hospital (1)

Chinese PLA General Hospital (1)

First Affiliated Hospital of Fujian Medical University (1)

First Affiliated Hospital of Wenzhou Medical University (1)

First Hospital of China Medical University (1)

Huashan Hospital (1)

Peking Union Medical College Hospital (1)

Roche Pharma AG (1)

Xinqiao Hospital of Chongqing (1)

Intervention

alectinib (1)

blood sample (1)

hcq/cq and cab combined treatment (1)

ice swimming (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

Funder Type

Other (4)

Study Type

Interventional (2)

Observational (2)

resistance, disease

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Prostate Cancer, Resistance, Disease, MicroRNAs Trial in Tours (Blood sample)

Recruiting

Prostate Cancer
+2 more

Blood sample

Tours, France

CANCEL

May 17, 2022

COVID-19 in Polish Ice Swimmers.

Completed

Covid19
+4 more

Ice Swimming

Wrocław, Dolny Slask, Poland
+2 more

Apr 6, 2021

ALK Translocations in Serial Blood Samples From Non-Small Cell

Enrolling by invitation

Lung Cancer
+3 more

Alectinib

Aarhus, Denmark

Aarhus University Hospital

Jan 30, 2021

Resistance, Disease, Prolactinoma Trial in China (HCQ/CQ and CAB combined treatment)

Unknown status

Resistance, Disease
Prolactinoma

HCQ/CQ and CAB combined treatment

Beijing, Beijing, China
+8 more

Oct 14, 2018